---
title: "Why Tonix Pharmaceuticals  ( TNXP )  Stock Is Climbing This Week"
description: "Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a key, upcoming catalyst. The next 100%+ earnings move could hit this month. "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/252894949.md"
published_at: "2025-08-13T15:34:45.000Z"
---

# Why Tonix Pharmaceuticals  ( TNXP )  Stock Is Climbing This Week

> Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a key, upcoming catalyst. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →

Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a key, upcoming catalyst. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →

### Related Stocks

- [TNXP.US - Tonix Pharma](https://longbridge.com/en/quote/TNXP.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Tonix Pharma 公佈投資者演示，重點介紹 FDA 批准和研發管線的進展 | Tonix Pharmaceuticals Holding Corp. 發佈了一份投資者演示文稿，詳細介紹了其業務和臨牀活動。該公司報告現金為 1.9 億美元，無債務，現金流可持續到 2027 年第一季度。它擁有三款獲得 FDA 批准的產品 | [Link](https://longbridge.com/en/news/272109130.md) |
| Tonix Pharma 在 2000 萬美元直接股票交易後股價上漲 | Tonix Pharmaceuticals (TNXP) 的股票在盤前交易中上漲了 0.9%，至 16.40 美元，此前該公司向 Steven Cohen 的投資公司 Point72 進行了 2000 萬美元的註冊直接發行普通股和預先融資的 | [Link](https://longbridge.com/en/news/270999773.md) |
| Tonix Pharma 發佈了關於萊姆病的單克隆抗體預防數據 | Tonix 醫藥控股公司發佈了一份文件，詳細介紹了一種旨在預防萊姆病的新型單克隆抗體。該文件包括流行病學數據、單克隆抗體治療與疫苗的比較，以及抗體的起效時間和給藥信息。完整文件可通過提供的鏈接訪問。此新聞簡報由公共技術公司生成，僅供信息參考 | [Link](https://longbridge.com/en/news/271031125.md) |
| Tonix 醫藥控股公司發佈了關於單克隆抗體 TNX-4800 用於預防萊姆病的報告 | Tonix Pharmaceuticals Holding Corp. 發佈了一份關於 TNX-4800 的報告，這是一種用於預防萊姆病的單克隆抗體。該文件強調了萊姆病日益嚴重的流行情況以及單克隆抗體作為預防治療的潛力。這份由人工智能生成的 | [Link](https://longbridge.com/en/news/270740197.md) |
| Tonix Pharma 宣佈進行 2000 萬美元的發行，其中包括預先資助的認股權證 | Tonix Pharmaceuticals Holding Corp. 宣佈進行一項 2000 萬美元的融資，與 Point72 簽署了一項證券購買協議，購買 615,025 股普通股，每股價格為 16.26 美元。同時，還發行了相同數量的 | [Link](https://longbridge.com/en/news/270996879.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.